Sponsor Pipeline

Suzhou Immunofoco Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1/2
1
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07103668 A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric… Gastric Adenocarcinoma Recruiting
Phase 1/2
NCT07644403 Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors. Epithelial Cancer Patients Enrolling by Invitation
Early Phase 1
NCT07376642 A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to… Relapsed/Refractory B-cell Non-Hodgkin Lymphoma Recruiting
NCT07493135 A Study of IMV102 in Patients With Relapsed/Refractory Multiple Myeloma Relapsed/Refractory Multiple Myeloma Recruiting
Disease Areas
Non-Hodgkin Lymphoma (1) Multiple Myeloma (1)
Get alerts when Suzhou Immunofoco Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free